Loading...
XSHG
603301
Market cap780mUSD
Jul 15, Last price  
20.71CNY
1D
-1.38%
1Q
1.02%
IPO
-45.50%
Name

ZHENDE MEDICAL CO LTD

Chart & Performance

D1W1MN
P/E
27.80
P/S
1.34
EPS
0.74
Div Yield, %
2.38%
Shrs. gr., 5y
8.24%
Rev. gr., 5y
23.63%
Revenues
4.13b
-32.76%
986,914,9901,021,012,4171,034,899,3121,306,442,5401,428,856,6841,867,727,91510,398,545,6385,091,572,4476,137,634,4314,127,044,055
Net income
198m
-70.82%
21,774,56079,059,48282,841,569121,769,114130,203,577156,890,0612,549,453,200595,861,926679,878,142198,399,010
CFO
452m
-63.72%
83,626,714142,699,376138,574,134182,343,95720,245,774197,762,7363,120,839,894817,629,3181,246,045,055452,107,162
Dividend
Jul 03, 20240.5 CNY/sh

Profile

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment. It offers medical wound dressing products, sensory control protection products, pressure therapy and immobilization products, and stoma and chronic wounds, and home care products. The company sells its products approximately in 73 countries, including Europe, the United States, and China. The company was founded in 1994 and is based in Shaoxing, China.
URL
http://www.zhende.com/
IPO date
Apr 12, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,127,044
-32.76%
6,137,634
20.54%
Cost of revenue
3,489,890
4,835,827
Unusual Expense (Income)
NOPBT
637,154
1,301,807
NOPBT Margin
15.44%
21.21%
Operating Taxes
5,492
98,704
Tax Rate
0.86%
7.58%
NOPAT
631,661
1,203,103
Net income
198,399
-70.82%
679,878
14.10%
Dividends
(423,716)
(136,323)
Dividend yield
6.45%
1.51%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
220,145
139,128
Long-term debt
278,625
461,974
Deferred revenue
231,984
176,001
Other long-term liabilities
1
1
Net debt
(748,087)
(1,611,817)
Cash flow
Cash from operating activities
452,107
1,246,045
CAPEX
(599,235)
Cash from investing activities
(1,057,854)
Cash from financing activities
(423,284)
455,998
FCF
333,267
1,172,740
Balance
Cash
1,207,412
2,174,775
Long term investments
39,445
38,144
Excess cash
1,040,504
1,906,037
Stockholders' equity
3,648,974
3,993,529
Invested Capital
5,255,420
4,468,044
ROIC
12.99%
27.62%
ROCE
10.09%
20.36%
EV
Common stock shares outstanding
268,107
237,328
Price
24.52
-35.56%
38.05
-25.93%
Market cap
6,573,978
-27.20%
9,030,347
-22.41%
EV
6,064,695
7,633,846
EBITDA
880,122
1,496,085
EV/EBITDA
6.89
5.10
Interest
30,913
33,539
Interest/NOPBT
4.85%
2.58%